Biochemical and structural mechanisms at the filoviral-host interface

丝状病毒-宿主界面的生化和结构机制

基本信息

  • 批准号:
    10555055
  • 负责人:
  • 金额:
    $ 111.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-07-07 至 2028-05-31
  • 项目状态:
    未结题

项目摘要

RP01 Project Summary/Abstract for Biochemical and structural mechanisms at the filoviral-host interface The recent filoviral outbreaks, including the 2013-2016 Ebola virus (EBOV) outbreak in West Africa that introduced the virus to other continents, highlight the imminent threat to global health posed by filoviruses and the urgent need for basic and translational efforts. The current COVID-19 pandemic further illustrates the significance of understanding infectious diseases. While recent efforts to develop countermeasures have resulted in vaccine candidates and some therapeutics, filoviruses remain a considerable threat to human health and key questions are still outstanding. There are substantial gaps in our understanding of host-viral interactions that contribute to disease, including how viral proteins limit host responses and assemble into infectious particles. Work in Research Project 1 (RP01) will use proteomic, biochemical, and structural methods to identify and validate molecular mechanisms at the host-viral interface in cellular networks to address this gap. We will address these longstanding mechanistic questions using biochemical and hybrid structural methods, including mass spectrometry, NMR, X-ray crystallography, small angle X-ray scattering (SAXS), and cryoelectron microscopy (cryo-EM), cryoelectron tomography (cryo-TM) to characterize filoviral nucleocapsid (NC) interactions and to define high impact filoviral-host factor interactions modulating PTMs that impact the viral replication cycle, viral NC assembly, and egress. Our strong publication record, preliminary results from ongoing studies, and access to unique facilities and resources support these efforts. We are uniquely positioned due to our highly productive and collaborative team with complementary expertise and a prior record of co-authored studies with investigators in RP02, RP03, Core B, and Core C. Our Aims are: Aim 1. Determine the structural basis and dynamics of the filoviral nucleocapsid (NC) and define NC-host interactions; Aim 2. Develop Protein-protein interaction (PPI) maps that include post-translational modifications (PTMs) from virally infected cells for EBOV and MARV; and Aim 3. Define the molecular mechanisms for PPIs that contribute to filoviral infection defined by this project, RP02 and RP03. At the completion, we expect to define filoviral interaction with host factors that contribute to filoviral infection. Our arsenal of tools from mass spectrometry, biochemistry, and structural biology, together with work from the Research Projects and Scientific Cores within the PPG, enable us to clearly define each contribution to filoviral infection and identify new targets for antivirals.
RP 01丝状病毒宿主的生化和结构机制的项目总结/摘要 接口 最近爆发的丝状病毒疫情,包括2013-2016年西非爆发的埃博拉病毒(EBOV), 将该病毒引入其他大陆,强调丝状病毒对全球健康构成的迫在眉睫的威胁, 迫切需要基本的和转化的努力。当前的COVID-19疫情进一步说明了 了解传染病的重要性。虽然最近为制定对策所作的努力 尽管丝状病毒已经产生了疫苗候选物和一些治疗剂,但丝状病毒仍然对人类构成相当大的威胁。 卫生和关键问题仍然悬而未决。在我们对宿主病毒的理解上, 导致疾病的相互作用,包括病毒蛋白如何限制宿主反应并组装成 传染性粒子研究项目1(RP 01)的工作将使用蛋白质组学,生物化学和结构 鉴定和验证细胞网络中宿主-病毒界面的分子机制的方法, 弥补这一差距。我们将利用生物化学和混合动力学来解决这些长期存在的机械问题。 结构方法,包括质谱、NMR、X射线晶体学、小角X射线散射 (SAXS)和冷冻电子显微镜(cryo-EM)、冷冻电子断层扫描(cryo-TM)来表征丝状病毒 核衣壳(NC)相互作用,并定义调节PTM的高影响丝状病毒-宿主因子相互作用, 影响病毒复制周期、病毒NC组装和外出。我们强大的出版记录,初步 正在进行的研究的结果以及获得独特设施和资源的机会支持这些努力。我们 独特的定位,由于我们的高效和协作的团队与互补的专业知识和 RP 02、RP 03、核心B和核心C中与研究者共同撰写研究的既往记录。我们的目标:Aim 1.确定丝状病毒核衣壳(NC)的结构基础和动力学,并定义NC宿主 目标2.开发包括翻译后修饰的蛋白质相互作用(PPI)图谱 用于EBOV和MARV的来自病毒感染细胞的PTM;和Aim 3。定义PPI的分子机制 导致本项目定义的丝状病毒感染,RP 02和RP 03。在完成时,我们希望 定义丝状病毒与导致丝状病毒感染的宿主因子的相互作用。我们的武器库从大众 光谱,生物化学和结构生物学,以及研究项目的工作, PPG中的科学核心使我们能够清楚地定义对丝状病毒感染的每一种贡献,并确定 抗病毒药物的新靶点

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gaya K. Amarasinghe其他文献

Disruption of Ebola NPsup0/supVP35 Inclusion Body-like Structures reduce Viral Infection
破坏埃博拉病毒核蛋白(N)VP35 包涵体样结构可降低病毒感染
  • DOI:
    10.1016/j.jmb.2023.168241
  • 发表时间:
    2023-10-15
  • 期刊:
  • 影响因子:
    4.500
  • 作者:
    Chao Wu;Nicole D. Wagner;Austin B. Moyle;Annie Feng;Nitin Sharma;Sarah H. Stubbs;Callie Donahue;Robert A. Davey;Michael L. Gross;Daisy W. Leung;Gaya K. Amarasinghe
  • 通讯作者:
    Gaya K. Amarasinghe
Molecular basis for human respiratory syncytial virus transcriptional regulator NS1 interactions with MED25
人类呼吸道合胞病毒转录调节因子 NS1 与 MED25 相互作用的分子基础
  • DOI:
    10.1038/s41467-025-58216-4
  • 发表时间:
    2025-03-25
  • 期刊:
  • 影响因子:
    15.700
  • 作者:
    Parismita Kalita;Oam Khatavkar;Grace Uwase;Yulia Korshunova;Yuying Hu;Nicole D. Wagner;Jian Xu;Jiehong Pan;Jay C. Nix;Michael L. Gross;Steven L. Brody;Dominika Borek;Gaya K. Amarasinghe;Jacqueline E. Payton;Daisy W. Leung
  • 通讯作者:
    Daisy W. Leung
Dynamic Origins of Interdomain Cooperativity in the Vav1 Proto-Oncoprotein
  • DOI:
    10.1016/j.bpj.2008.12.907
  • 发表时间:
    2009-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    Michael K. Rosen;Pilong Li;Ilidio R.S. Martins;Gaya K. Amarasinghe;Bingke Yu;Junko Umetani
  • 通讯作者:
    Junko Umetani
2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales
  • DOI:
    10.1007/s00705-020-04731-2
  • 发表时间:
    2020-09-04
  • 期刊:
  • 影响因子:
    2.500
  • 作者:
    Jens H. Kuhn;Scott Adkins;Daniela Alioto;Sergey V. Alkhovsky;Gaya K. Amarasinghe;Simon J. Anthony;Tatjana Avšič-Županc;María A. Ayllón;Justin Bahl;Anne Balkema-Buschmann;Matthew J. Ballinger;Tomáš Bartonička;Christopher Basler;Sina Bavari;Martin Beer;Dennis A. Bente;Éric Bergeron;Brian H. Bird;Carol Blair;Kim R. Blasdell;Steven B. Bradfute;Rachel Breyta;Thomas Briese;Paul A. Brown;Ursula J. Buchholz;Michael J. Buchmeier;Alexander Bukreyev;Felicity Burt;Nihal Buzkan;Charles H. Calisher;Mengji Cao;Inmaculada Casas;John Chamberlain;Kartik Chandran;Rémi N. Charrel;Biao Chen;Michela Chiumenti;Il-Ryong Choi;J. Christopher S. Clegg;Ian Crozier;John V. da Graça;Elena Dal Bó;Alberto M. R. Dávila;Juan Carlos de la Torre;Xavier de Lamballerie;Rik L. de Swart;Patrick L. Di Bello;Nicholas Di Paola;Francesco Di Serio;Ralf G. Dietzgen;Michele Digiaro;Valerian V. Dolja;Olga Dolnik;Michael A. Drebot;Jan Felix Drexler;Ralf Dürrwald;Lucie Dufkova;William G. Dundon;W. Paul Duprex;John M. Dye;Andrew J. Easton;Hideki Ebihara;Toufic Elbeaino;Koray Ergünay;Jorlan Fernandes;Anthony R. Fooks;Pierre B. H. Formenty;Leonie F. Forth;Ron A. M. Fouchier;Juliana Freitas-Astúa;Selma Gago-Zachert;George Fú Gāo;María Laura García;Adolfo García-Sastre;Aura R. Garrison;Aiah Gbakima;Tracey Goldstein;Jean-Paul J. Gonzalez;Anthony Griffiths;Martin H. Groschup;Stephan Günther;Alexandro Guterres;Roy A. Hall;John Hammond;Mohamed Hassan;Jussi Hepojoki;Satu Hepojoki;Udo Hetzel;Roger Hewson;Bernd Hoffmann;Seiji Hongo;Dirk Höper;Masayuki Horie;Holly R. Hughes;Timothy H. Hyndman;Amara Jambai;Rodrigo Jardim;Dàohóng Jiāng;Qi Jin;Gilda B. Jonson;Sandra Junglen;Serpil Karadağ;Karen E. Keller;Boris Klempa;Jonas Klingström;Gary Kobinger;Hideki Kondō;Eugene V. Koonin;Mart Krupovic;Gael Kurath;Ivan V. Kuzmin;Lies Laenen;Robert A. Lamb;Amy J. Lambert;Stanley L. Langevin;Benhur Lee;Elba R. S. Lemos;Eric M. Leroy;Dexin Li;Jiànróng Lǐ;Mifang Liang;Wénwén Liú;Yàn Liú;Igor S. Lukashevich;Piet Maes;William Marciel de Souza;Marco Marklewitz;Sergio H. Marshall;Giovanni P. Martelli;Robert R. Martin;Shin-Yi L. Marzano;Sébastien Massart;John W. McCauley;Nicole Mielke-Ehret;Angelantonio Minafra;Maria Minutolo;Ali Mirazimi;Hans-Peter Mühlbach;Elke Mühlberger;Rayapati Naidu;Tomohide Natsuaki;Beatriz Navarro;José A. Navarro;Sergey V. Netesov;Gabriele Neumann;Norbert Nowotny;Márcio R. T. Nunes;Are Nylund;Arnfinn L. Økland;Renata C. Oliveira;Gustavo Palacios;Vicente Pallas;Bernadett Pályi;Anna Papa;Colin R. Parrish;Alex Pauvolid-Corrêa;Janusz T. Pawęska;Susan Payne;Daniel R. Pérez;Florian Pfaff;Sheli R. Radoshitzky;Aziz-ul Rahman;Pedro L. Ramos-González;Renato O. Resende;Carina A. Reyes;Bertus K. Rima;Víctor Romanowski;Gabriel Robles Luna;Paul Rota;Dennis Rubbenstroth;Jonathan A. Runstadler;Daniel Ruzek;Sead Sabanadzovic;Jiří Salát;Amadou Alpha Sall;Maria S. Salvato;Kamil Sarpkaya;Takahide Sasaya;Martin Schwemmle;Muhammad Z. Shabbir;Xiǎohóng Shí;Zhènglì Shí;Yukio Shirako;Peter Simmonds;Jana Širmarová;Manuela Sironi;Sophie Smither;Teemu Smura;Jin-Won Song;Kirsten M. Spann;Jessica R. Spengler;Mark D. Stenglein;David M. Stone;Petra Straková;Ayato Takada;Robert B. Tesh;Natalie J. Thornburg;Keizō Tomonaga;Noël Tordo;Jonathan S. Towner;Massimo Turina;Ioannis Tzanetakis;Rainer G. Ulrich;Anna Maria Vaira;Bernadette van den Hoogen;Arvind Varsani;Nikos Vasilakis;Martin Verbeek;Victoria Wahl;Peter J. Walker;Hui Wang;Jianwei Wang;Xifeng Wang;Lin-Fa Wang;Tàiyún Wèi;Heather Wells;Anna E. Whitfield;John V. Williams;Yuri I. Wolf;Zhìqiáng Wú;Xin Yang;Xīnglóu Yáng;Xuejie Yu;Natalya Yutin;F. Murilo Zerbini;Tong Zhang;Yong-Zhen Zhang;Guohui Zhou;Xueping Zhou
  • 通讯作者:
    Xueping Zhou

Gaya K. Amarasinghe的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gaya K. Amarasinghe', 18)}}的其他基金

Characterizing the role of LDL related receptor 1 (Lrp1) as host entry factor for multiple bunyaviruses
描述 LDL 相关受体 1 (Lrp1) 作为多种布尼亚病毒宿主进入因子的作用
  • 批准号:
    10667857
  • 财政年份:
    2023
  • 资助金额:
    $ 111.25万
  • 项目类别:
HSP90 paralog selective small molecules as anti-old-world alpha-viral therapeutic leads.
HSP90 旁系同源选择性小分子作为抗旧世界 α 病毒治疗先导药物。
  • 批准号:
    10753347
  • 财政年份:
    2023
  • 资助金额:
    $ 111.25万
  • 项目类别:
Discovery of Bunyaviral Endonuclease Inhibitors for Antiviral Therapy
用于抗病毒治疗的布尼亚病毒核酸内切酶抑制剂的发现
  • 批准号:
    10481430
  • 财政年份:
    2022
  • 资助金额:
    $ 111.25万
  • 项目类别:
Discovery of Bunyaviral Endonuclease Inhibitors for Antiviral Therapy
用于抗病毒治疗的布尼亚病毒核酸内切酶抑制剂的发现
  • 批准号:
    10683329
  • 财政年份:
    2022
  • 资助金额:
    $ 111.25万
  • 项目类别:
Identification and Characterization of Entry Factors Critical for Rift Valley Fever Virus Infection and Pathogenesis
裂谷热病毒感染和发病机制关键进入因子的鉴定和表征
  • 批准号:
    10375591
  • 财政年份:
    2021
  • 资助金额:
    $ 111.25万
  • 项目类别:
Development and characterization of engineered therapeutic antibodies against SARS-CoV-2
针对 SARS-CoV-2 的工程化治疗抗体的开发和表征
  • 批准号:
    10865147
  • 财政年份:
    2021
  • 资助金额:
    $ 111.25万
  • 项目类别:
Development and characterization of engineered therapeutic antibodies against SARS-CoV-2
针对 SARS-CoV-2 的工程化治疗抗体的开发和表征
  • 批准号:
    10458689
  • 财政年份:
    2021
  • 资助金额:
    $ 111.25万
  • 项目类别:
Development and characterization of engineered therapeutic antibodies against SARS-CoV-2
针对 SARS-CoV-2 的工程化治疗抗体的开发和表征
  • 批准号:
    10669612
  • 财政年份:
    2021
  • 资助金额:
    $ 111.25万
  • 项目类别:
Identification and Characterization of Entry Factors Critical for Rift Valley Fever Virus Infection and Pathogenesis
裂谷热病毒感染和发病机制关键进入因子的鉴定和表征
  • 批准号:
    10573316
  • 财政年份:
    2021
  • 资助金额:
    $ 111.25万
  • 项目类别:
Development and characterization of engineered therapeutic antibodies against SARS-CoV-2
针对 SARS-CoV-2 的工程化治疗抗体的开发和表征
  • 批准号:
    10240126
  • 财政年份:
    2021
  • 资助金额:
    $ 111.25万
  • 项目类别:

相似海外基金

A mixed methods approach to address multi-level barriers to care for migratory men living with HIV in South Africa
采用混合方法解决照顾南非艾滋病毒携带者移民男性的多层次障碍
  • 批准号:
    10403224
  • 财政年份:
    2022
  • 资助金额:
    $ 111.25万
  • 项目类别:
Using the EPIC model to build transdisciplinary communities of practice that effectively address urban resilience in Africa and Asia
使用 EPIC 模型建立跨学科实践社区,有效解决非洲和亚洲的城市复原力问题
  • 批准号:
    2103692
  • 财政年份:
    2022
  • 资助金额:
    $ 111.25万
  • 项目类别:
    Standard Grant
A mixed methods approach to address multi-level barriers to care for migratory men living with HIV in South Africa
采用混合方法解决照顾南非艾滋病毒携带者移民男性的多层次障碍
  • 批准号:
    10689689
  • 财政年份:
    2022
  • 资助金额:
    $ 111.25万
  • 项目类别:
Complex intervention to optimise adolescent BMI pre-conception to address the double burden of malnutrition: A RCT in rural and urban South Africa
优化青少年孕前体重指数以解决营养不良的双重负担的复杂干预措施:南非农村和城市的随机对照试验
  • 批准号:
    MR/V005790/1
  • 财政年份:
    2021
  • 资助金额:
    $ 111.25万
  • 项目类别:
    Research Grant
Complex intervention to optimise adolescent BMI pre-conception to address the double burden of malnutrition: A RCT in rural and urban South Africa
优化青少年孕前体重指数以解决营养不良的双重负担的复杂干预措施:南非农村和城市的随机对照试验
  • 批准号:
    MR/V005790/2
  • 财政年份:
    2021
  • 资助金额:
    $ 111.25万
  • 项目类别:
    Research Grant
An implementation science approach to address multi-level barriers to cancer screening among women living with HIV in South Africa
一种实施科学方法,以解决南非艾滋病毒感染妇女癌症筛查的多层次障碍
  • 批准号:
    10242935
  • 财政年份:
    2020
  • 资助金额:
    $ 111.25万
  • 项目类别:
A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa
解决东非艾滋病毒流行的持续驱动因素的多部门战略
  • 批准号:
    10267216
  • 财政年份:
    2020
  • 资助金额:
    $ 111.25万
  • 项目类别:
A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa
解决东非艾滋病毒流行的持续驱动因素的多部门战略
  • 批准号:
    10085144
  • 财政年份:
    2020
  • 资助金额:
    $ 111.25万
  • 项目类别:
A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa
解决东非艾滋病毒流行的持续驱动因素的多部门战略
  • 批准号:
    10438844
  • 财政年份:
    2020
  • 资助金额:
    $ 111.25万
  • 项目类别:
Teaching empowerment: Grass-roots educators' strategies to address gender equity in the context of the HIV epidemic in South Africa
教学赋权:基层教育工作者在南非艾滋病毒流行背景下解决性别平等问题的战略
  • 批准号:
    218055
  • 财政年份:
    2010
  • 资助金额:
    $ 111.25万
  • 项目类别:
    Studentship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了